vgx-3100
Vaccineexperimental
Clinical trial activity
8 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
2
Phase 4
0
Earliest trial started May 1, 2008 (NCT00685412)
Timeline
Indications
Studied for
- Anus Neoplasms · Phase 2
- Carcinoma, Squamous Cell · Phase 2
- Cervical Intraepithelial Neoplasia · Phase 2
- Genital Neoplasms, Female · Phase 2
- HIV Infections · Phase 2
- Human papillomavirus 16 · Phase 2
- Neoplasms · Phase 3
- Papillomavirus Infections · Phase 2
- Squamous Intraepithelial Lesions · Phase 3
- Uterine Cervical Dysplasia · Phase 3
- Vulvar Neoplasms · Phase 2
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vgx 3100
- vgx-3100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03721978 | Phase 3 | Apr 2, 2019 | Inovio Pharmaceuticals |
| NCT03603808 | Phase 2 | Sep 21, 2018 | AIDS and Cancer Specimen Resource, AIDS Malignancy Consortium, Inovio Pharmaceuticals, National Cancer Institute (NCI), The EMMES Corporation, University of Arkansas |
| NCT03499795 | Phase 2 | May 3, 2018 | Inovio Pharmaceuticals |
| NCT03185013 | Phase 3 | Jun 28, 2017 | Inovio Pharmaceuticals |
| NCT03180684 | Phase 2 | Jun 26, 2017 | Inovio Pharmaceuticals |
| NCT01304524 | Phase 2 | Apr 1, 2011 | Inovio Pharmaceuticals, Johns Hopkins University, Lyndhurst Gynecologic Associates, University of California, Irvine |
| NCT01188850 | Phase 1 | Jul 1, 2010 | Inovio Pharmaceuticals, Laurel Highlands, OB/GYN, P.C., Lyndhurst Gynecologic Associates |
| NCT00685412 | Phase 1 | May 1, 2008 | Inovio Pharmaceuticals, Laurel Highlands, OB/GYN, P.C., Lyndhurst Gynecologic Associates, University of Pennsylvania |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals | For profit | 8 | 7 | 3 | 2008 |
| Lyndhurst Gynecologic Associates | Academic/Hospital | 3 | 0 | 2 | 2008 |
| Laurel Highlands, OB/GYN, P.C. | Academic/Hospital | 2 | 0 | 1 | 2008 |
| AIDS and Cancer Specimen Resource | Academic/Hospital | 1 | 0 | 1 | 2018 |
| AIDS Malignancy Consortium | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2018 |
| The EMMES Corporation | For profit | 1 | 0 | 1 | 2018 |
| University of Arkansas | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of California, Irvine | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2008 |
11 organizations
Page 1 / 1